Biologic therapeutics and molecular profiling to optimize wound healing

Gynecologic Oncology

Volumn 111, Issue 2 SUPPL., 2008, Pages

  Menke, Marie N ^a   Menke, Nathan B ^a   Boardman, Cecelia H ^a   Diegelmann, Robert F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Delayed healing; Malignancy; Radiation; Wound

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANDROSTENEDIOL; ANTINEOPLASTIC AGENT; COTRIMOXAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PIPERACILLIN PLUS TAZOBACTAM; STEROID; VANCOMYCIN;

ARTICLE; CANCER PATIENT; CHRONIC INFLAMMATION; COMORBIDITY; EXTRACELLULAR MATRIX; HUMAN; MALNUTRITION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

CHRONIC DISEASE; HUMANS; WOUND HEALING; WOUND INFECTION; WOUNDS AND INJURIES;

EID: 54549105174     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.07.052     Document Type: Article

References (49)

1. Menke N., Ward K.R., and Diegelmann R. Non-healing wounds. Emerg Med Rep 28 4 (2007)
2. Menke N.B., Ward K.R., Witten T.M., Bonchev D.G., and Diegelmann R.F. Impaired wound healing. Clin Dermatol 25 (2007) 19-25
3. Lazarus G.S., Cooper D.M., Knighton D.R., Margolis D.J., Pecoraro R.E., Rodeheaver G., and Robson M.C. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 130 (1994) 489-493
4. Mustoe T.A., O'Shaughnessy K., and Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 117 7 Suppl (2006) 35S-41S
5. Yager D.R., Zhang L.Y., Liang H.X., Diegelmann R.F., and Cohen I.K. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 107 (1996) 743-748
6. Wysocki A.B., Staiano-Coico L., and Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101 (1993) 64-68
7. Nwomeh B.C., Liang H.X., Cohen I.K., and Yager D.R. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 81 (1999) 189-195
8. Nwomeh B.C., Liang H.X., Diegelmann R.F., Cohen I.K., and Yager D.R. Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds. Wound Repair Regen 6 (1998) 127-134
9. Lobmann R., Zacheja S., Houdek P., Moll I., and Lobmann R. Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes before and after transplantation into an ex vivo wound-healing model. Diabetes Care 31 (2008) 114-120
10. Bullen E.C., Longaker M.T., Updike D.L., Benton R., Ladin D., Hou Z., and Howard E.W. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 104 (1995) 236-240
11. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 320 (1989) 365-376
12. Rao C.N., Ladin D.A., Liu Y.Y., Chilukuri K., Hou Z.Z., and Woodley D.T. Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. J Invest Dermatol 105 (1995) 572-578
13. Grinnell F., and Zhu M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol 106 (1996) 335-341
14. Cooper D.M., Yu E.Z., Hennessey P., Ko F., and Robson M.C. Determination of endogenous cytokines in chronic wounds. Ann Surg 219 (1994) 688-691 discussion 691-2
15. Falanga V. Growth factors and chronic wounds: the need to understand the microenvironment. J Dermatol 19 (1992) 667-672
16. Bennett N.T., and Schultz G.S. Growth factors and wound healing: part II. Role in normal and chronic wound healing. Am J Surg 166 (1993) 74-81
17. Menke N., and Diegelmann R. Biochemical pathways of wound healing: implication for development of disease-specific diagnostics. In: Makowski G. (Ed). Advances in Clinical Chemistry (2006), Elsevier 167-187
18. Steed D.L. Wound-healing trajectories. Surg Clin North Am 83 (2003) 547-555 vi-vii
19. Robson M.C., Hill D.P., Woodske M.E., and Steed D.L. Wound healing trajectories as predictors of effectiveness of therapeutic agents. Arch Surg 135 (2000) 773-777
20. Siegel H.J., Long J.L., Watson K.M., and Fiveash J.B. Vacuum-assisted closure for radiation-associated wound complications. J Surg Oncol 96 (2007) 575-582
21. Liu X., Liu J.Z., Zhang E., Li P., Zhou P., Cheng T.M., and Zhou Y.G. Impaired wound healing after local soft X-ray irradiation in rat skin: time course study of pathology, proliferation, cell cycle, and apoptosis. J Trauma 59 (2005) 682-690
22. Kolb B.A., Buller R.E., Connor J.P., DiSaia P.J., and Berman M.L. Effects of early postoperative chemotherapy on wound healing. Obstet Gynecol 79 (1992) 988-992
23. Tintinalli J.E., Ma O.J., and Cline D.M. Tintinalli's Emergency Medicine: A Comprehensive Study Guide (2004), McGraw Hill
24. Marx J.A., Hockberger R.S., and Walls R.M. Rosen's Emergency Medicine: Concepts and Clinical Practice. 6th Ed (2006), PA: Mosby Elsevier, Philadelphia
25. Weiss E.A. Surgical management of cutaneous ulcers and pressure sores. Arch Surg 135 (2000) 874
26. Garcia A.D., and Thomas D.R. Assessment and management of chronic pressure ulcers in the elderly. Med Clin North Am 90 (2006) 925-944
27. Bowle P.G., Duerden B.I., and Armstrong D.G. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14 (2001) 244-269
28. Sumpio B.E. Foot ulcers. N Engl J Med 343 (2000) 787-793
29. London N.J.M., and Donnelly R. ABC of arterial and venous disease: ulcerated lower limb. BMJ 320 (2000) 1589-1591
30. Watkins P.J. ABC of diabetes: the diabetic foot. BMJ 326 (2003) 977-979
31. Sarkar P.K., and Ballantyne S. Management of leg ulcers. Postgrad Med J 76 (2000) 674-682
32. de Araujo T., Valencia I., Federman D.G., and Kirsner R.S. Managing the patient with venous ulcers. Ann Intern Med 138 (2003) 326-334
33. Nigam Y., Bexfield A., Thomas S., and Ratcliffe N.A. Maggot therapy: the science and implication for CAM part II-maggots combat infection. Evid Based Complement Alternat Med 3 (2006) 303-308
34. Nigam Y., Bexfield A., Thomas S., and Ratcliffe N.A. Maggot therapy: the science and implication for CAM part I-history and bacterial resistance. Evid Based Complement Alternat Med 3 (2006) 223-227
35. Seaman S. Dressing selection in chronic wound management. J Am Podiatr Med Assoc 92 (2002) 24-33
36. Shirakawa M., and Isseroff R.R. Topical negative pressure devices: use for enhancement of healing chronic wounds. Arch Dermatol 141 (2005) 1449-1453
37. Jones S.M., Banwell P.E., and Shakespeare P.G. Advances in wound healing: topical negative pressure therapy. Postgrad Med J 81 (2005) 353-357
38. Reddy M., Gill S.S., and Rochon P.A. Preventing pressure ulcers: a systematic review. JAMA 296 (2006) 974-984
39. Maciejewski M.L., Reiber G.E., Smith D.G., Wallace C., Hayes S., and Boyko E.J. Effectiveness of diabetic therapeutic footwear in preventing reulceration. Diabetes Care 27 (2004) 1774-1782
40. Yager D.R., Chen S.M., Ward S., Olutoye O.O., Diegelmann R.F., and Cohen I.K. The ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair Regen 5 (1997) 23-32
41. Marston W.A., Hanft J., Norwood P., Pollak R., and Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26 (2003) 1701-1705
42. Mathias S.D., Prebil L.A., Boyko W.L., and Fastenau J. Health-related quality of life in venous leg ulcer patients successfully treated with Apligraf: a pilot study. Adv Skin Wound Care 13 (2000) 76-78
43. Howell-Jones R.S., Wilson M.J., Hill K.E., Howard A.J., Price P.E., and Thomas D.W. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 55 (2005) 143-149
44. Gilbert D.N., Moellering R.C., and Eliopoulos G. The Sanford Guide to Antimicrobial Therapy. 36th ed (2006), Antimicrobial Therapy Inc, Sperryville, VA
45. Neovius E.B., Lind M.G., and Lind F.G. Hyperbaric oxygen therapy for wound complications after surgery in the irradiated head and neck: a review of the literature and a report of 15 consecutive patients. Head Neck 19 (1997) 315-322
46. Pitkin A.D., and Davies N.J.H. Hyperbaric oxygen therapy. CEACCP 1 (2001) 150-156
47. Feeser V., et al. Modulation of the deleterious effects of glucocorticoids on wound healing by immune regulating hormones. Acad Emerg Med 14 Suppl1 (2007) S147-S148
48. Feeser V, et al. Immune-regulating androstene hormones and their ability to reverse glucorticoid-inhibited wound closure shock. 2007;27(Suppl1):62.
49. Brem H., Stojadinovic O., Diegelmann R.F., Entero H., Lee B., Pastar I., et al. Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med 13 (2007) 30-39